(Q33542015)

27 July 2017

1 reference

title

Prognostic utility of myocardial viability assessment (English)

1 reference

27 July 2017

Iskander S

1

1 reference

27 July 2017

Iskandrian AE

series ordinal

2

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 March 1999

1 reference

American Journal of Cardiology

27 July 2017

published in

1 reference

27 July 2017

volume

83

1 reference

27 July 2017

issue

5

1 reference

27 July 2017

page(s)

696-702, A7

1 reference

Post-extrasystolic potentiation of ischemic myocardium by atrial stimulation

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

The hibernating myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

The stunned myocardium: prolonged, postischemic ventricular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Medical and cellular implications of stunning, hibernation, and preconditioning: an NHLBI workshop.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Pathophysiological mechanisms of chronic reversible left ventricular dysfunction due to coronary artery disease (hibernating myocardium).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Chronic myocardial hibernation in humans. From bedside to bench

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Pathophysiology of chronic left ventricular dysfunction. New insights from the measurement of absolute myocardial blood flow and glucose utilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Hibernating myocardium: an incomplete adaptation to ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Myocardial viability: methods of assessment and clinical relevance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Reversibility of cardiac wall-motion abnormalities predicted by positron tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

18F-2-deoxyglucose deposition and regional flow in pigs with chronically dysfunctional myocardium. Evidence for transmural variations in chronic hibernating myocardium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Myocardial cell death and apoptosis in hibernating myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Myocardial viability: contractile reserve or cell membrane integrity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Assessment of myocardial viability with 99mTc-sestamibi tomography before coronary bypass graft surgery: correlation with histopathology and postoperative improvement in cardiac function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Assessment of myocardial viability with 99mTc sestamibi in patients undergoing cardiac transplantation. A scintigraphic/pathological study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Comparison of baseline-nitrate technetium-99m sestamibi with rest-redistribution thallium-201 tomography in detecting viable hibernating myocardium and predicting postrevascularization recovery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Quantitative rest technetium-99m tetrofosmin imaging in predicting functional recovery after revascularization: comparison with rest-redistribution thallium-201

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Assessment of myocardial viability in patients with chronic coronary artery disease. Rest-4-hour-24-hour 201Tl tomography versus dobutamine echocardiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Dobutamine echocardiography and quantitative rest-redistribution 201Tl tomography in myocardial hibernation. Relation of contractile reserve to 201Tl uptake and comparative prediction of recovery of function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Nitroglycerin-augmented 201T1 reinjection enhances detection of reversible myocardial hypoperfusion. A randomized, double-blind, parallel, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Assessment of myocardial viability by use of 11C-acetate and positron emission tomography. Threshold criteria of reversible dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Delineation of myocardial stunning and hibernation by positron emission tomography in advanced coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Prediction of recovery of myocardial dysfunction after revascularization. Comparison of fluorine-18 fluorodeoxyglucose/thallium-201 SPECT, thallium-201 stress-reinjection SPECT and dobutamine echocardiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Proportionate reversible decreases in systolic function and myocardial oxygen consumption after modest reductions in coronary flow: hibernation versus stunning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Impaired fatty acid uptake in ischemic but viable myocardium identified by thallium-201 reinjection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

[18F]fluorodeoxyglucose single photon emission computed tomography: can it replace PET and thallium SPECT for the assessment of myocardial viability?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

"Hibernating" myocardium: asleep or part dead?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Effects of dobutamine at maximally tolerated dose on myocardial blood flow in humans with ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Factors influencing regional myocardial contractile response to inotropic stimulation. Analysis in humans with stable ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Effects of Dobutamine Stimulation on Myocardial Blood Flow, Glucose Metabolism, and Wall Motion in Normal and Dysfunctional Myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Analysis of microvascular integrity, contractile reserve, and myocardial viability after acute myocardial infarction by dobutamine echocardiography and myocardial contrast echocardiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Serial changes in response of hibernating myocardium to inotropic stimulation after revascularization: a dobutamine echocardiographic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Assessment of reversible dyssynergic segments after acute myocardial infarction: Dobutamine echocardiography versus thallium-201 single photon emission computed tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Stress-induced reversible and mild-to-moderate irreversible thallium defects: are they equally accurate for predicting recovery of regional left ventricular function after revascularization?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Chronic heart failure in the United States: a manifestation of coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Steps forward in the assessment of myocardial viability in left ventricular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Prediction of outcome of patients with life-threatening ventricular arrhythmias treated with automatic implantable cardioverter-defibrillators using SPECT perfusion imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Predictive value of planar 18F-fluorodeoxyglucose imaging for cardiac events in patients after acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Prognostic value of dobutamine-atropine stress echocardiography early after acute myocardial infarction. Echo Dobutamine International Cooperative (EDIC) Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Dobutamine stress echocardiography for risk stratification after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Superiority of nitrate-enhanced 201Tl over conventional redistribution 201Tl imaging for prognostic evaluation after myocardial infarction and thrombolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Preoperative Positron Emission Tomographic Viability Assessment and Perioperative and Postoperative Risk in Patients With Advanced Ischemic Heart Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Prognostic value of tomographic rest-redistribution thallium 201 imaging in medically treated patients with coronary artery disease and left ventricular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Prognostic value of rest-redistribution tomographic thallium-201 imaging in ischemic cardiomyopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Myocardial viability assessment in ischemic cardiomyopathy: benefits of coronary revascularization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Prognostic value of an increase in fluorine-18 deoxyglucose uptake in patients with myocardial infarction: comparison with stress thallium imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Combined assessment of left ventricular function and rest-redistribution regional myocardial thallium-201 activity for prognostic evaluation of patients with chronic coronary artery disease and left ventricular dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Results of coronary artery bypass grafting by a single surgeon in patients with left ventricular ejection fractions < or = 30%.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Prognosis of patients with severe left ventricular dysfunction after coronary artery bypass grafting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Quantitative planar rest-redistribution 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. Investigators of this Multicenter Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Cholesterol lowering and the use of healthcare resources. Results of the Scandinavian Simvastatin Survival Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Assessment of myocardial viability in patients with previous myocardial infarction by using single-photon emission computed tomography with a new metabolic tracer: [123I]-16-iodo-3-methylhexadecanoic acid (MIHA). Comparison with the rest-reinjection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Myocardial contrast echocardiography: 15 years of research and development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Methodology of a novel myocardial viability protocol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Exercise-induced ischemic arrhythmias in patients with previous myocardial infarction: role of perfusion and tissue viability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

Interpretation of outcomes of antiarrhythmic clinical trials: design features and population impact

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2898%2900973-4

10.1016/S0002-9149(98)00973-4

7 January 2021

Identifiers

DOI

1 reference

27 July 2017

1 reference